| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/21/1989 | US4882325 Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-amino-phenylacetamido)penicillanate napsylate and method of using the same |
| 11/21/1989 | US4882323 1,2,3,4,5,6-hexahydro[1,3,6]triazocino[1,1-a]benzimidazoles |
| 11/21/1989 | US4882322 3β,17β-hydroxy-substituted steroids and related steroidal compounds |
| 11/21/1989 | US4882319 Phosphonic acid substituted aromatic steroids as inhibitors of steroid 5-α-reductase |
| 11/21/1989 | US4882318 Administering heparin or suitable derivative |
| 11/21/1989 | US4882316 Pyrimidine derivatives |
| 11/21/1989 | US4882315 Aminoglycoside steroids, a process for their preparation, their use and pharmaceutical compositions containing them |
| 11/21/1989 | US4882314 4,6-0-benzylidene-d-glucopyranose |
| 11/21/1989 | US4882170 Sodium cromolyn as antiallergen/antiinflammatory for endotracheal intubation |
| 11/21/1989 | US4882164 Parenteral micelle solutions |
| 11/21/1989 | US4882163 Moxonidine and fatty acid mixture |
| 11/21/1989 | US4882161 Chewable, non-gritty calcium citrate tablet |
| 11/21/1989 | US4882147 Substituted with mercapto groups and fluorine at 5 position of cytosine and uracil bases |
| 11/21/1989 | US4882146 Preventing ADP-ribosylation of G-proteins in a living subject |
| 11/21/1989 | US4882144 Solid, rapidly released medicament preparations containing dihydropyridines, and processes for their preparation |
| 11/21/1989 | US4882142 Antitumor |
| 11/21/1989 | US4882137 Coated veterinary implants |
| 11/21/1989 | CA1263120A1 Process for the preparation of n-sulfamyl-3-(2- guanidino-thiazol-4-yl-methylthio)-propionamidine |
| 11/21/1989 | CA1263118A1 1,6-naphthyridine derivatives, process for the preparation and use thereof |
| 11/21/1989 | CA1263087A1 Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions |
| 11/21/1989 | CA1263086A1 Method for producing oncolysis |
| 11/16/1989 | WO1989010963A1 Process for the biochemical oxidation of steroids and genetically engineered cells to be used therefor |
| 11/16/1989 | WO1989010961A1 Peptide analogs and their use as haptens to elicit catalytic antibodies |
| 11/16/1989 | WO1989010929A2 New l-fucose analogs, method of preparation, application of such analogs to the preparation of new glycals, anthracyclines obtained with said glycals and utilization of said anthracyclines as drugs |
| 11/16/1989 | WO1989010928A1 Platinum-polymer complexes and their use as antitumor agents |
| 11/16/1989 | WO1989010926A1 1,1-dioxo-cephem-4-carbothiolic acid derivatives |
| 11/16/1989 | WO1989010925A1 Novel compounds and treatment |
| 11/16/1989 | WO1989010924A1 Indazole derivatives |
| 11/16/1989 | WO1989010923A1 Derivatives of purine, process for their preparation and a pharmaceutical preparation |
| 11/16/1989 | WO1989010919A1 Carbostyril derivatives |
| 11/16/1989 | WO1989010918A1 Phenylalkanoylamine derivatives, process for their preparation, and their uses |
| 11/16/1989 | WO1989010917A2 Renin inhibitors, process for producing them and use thereof |
| 11/16/1989 | WO1989010757A1 New ophthalmic preparation for treating glaucoma |
| 11/16/1989 | WO1989010754A1 Therapeutic methods using catalytic antibodies |
| 11/16/1989 | WO1989010752A1 Retroviral protease inhibitors |
| 11/16/1989 | WO1989010750A1 Topical composition |
| 11/16/1989 | WO1989010746A2 Blood substitute |
| 11/16/1989 | WO1989010745A1 Compositions and in situ methods for forming films on body tissue |
| 11/16/1989 | WO1989010744A1 Neurologically active compounds |
| 11/16/1989 | WO1989010743A1 Long lasting composition of propafenone and quinidine for treatment of cardiac conditions |
| 11/16/1989 | WO1989010742A1 Method for treating autoimmune disease using succinylacetone |
| 11/16/1989 | WO1989010741A1 Anxiolytic/anti-depressant 2,3-dihydro-1h-phenalen-2-amines |
| 11/16/1989 | WO1989005644A3 Thienotricyclene for the treatment of bronchial diseases |
| 11/16/1989 | DE3914672A1 Chemisches verfahren Chemical methods |
| 11/16/1989 | DE3914658A1 Chemisches verfahren Chemical methods |
| 11/16/1989 | DE3815473A1 System of active substances for lipid exchange with target structures |
| 11/15/1989 | EP0342182A1 Derivatives of 5-aminomethyl-2-furan methanol, their preparation and use |
| 11/15/1989 | EP0342139A2 Use of arginine aspartate for the manufacture of a medicament for treating certain inflictions of the memory |
| 11/15/1989 | EP0342115A1 Sulfurized eicosanoids and their use in pharmacy and cosmetics |
| 11/15/1989 | EP0342106A1 Controlled release tablets containing water soluble dilatizem salts and preparation thereof |
| 11/15/1989 | EP0342105A1 2-Adamantyl-3-isothiazolin-4-ones, process for their preparation and their use as bactericides and fungicides |
| 11/15/1989 | EP0342056A2 Cosmetic composition |
| 11/15/1989 | EP0342055A2 Use of pyroglutamic acid alkyl esters for the manufacture of a medicament for the treatment of ichthyosis |
| 11/15/1989 | EP0342054A2 Cosmetic composition |
| 11/15/1989 | EP0342030A2 Use of a thromboxane receptor antagonist to complement arterial surgery |
| 11/15/1989 | EP0342003A1 Use of 15-ketoprostaglandin E or F compounds for uterine contraction |
| 11/15/1989 | EP0341991A2 Method for recovery of antibiotics from mother liquors and novel pharmaceutically-acceptable salts thereof |
| 11/15/1989 | EP0341990A2 Cephalosporins, process for their preparation and pharmaceutical compositions |
| 11/15/1989 | EP0341974A2 Macrolide compounds |
| 11/15/1989 | EP0341973A2 Macrolide compounds |
| 11/15/1989 | EP0341972A2 Macrolide compounds |
| 11/15/1989 | EP0341951A2 Antimicrobial superabsorbent compositions and methods |
| 11/15/1989 | EP0341948A2 Cephalosporins, process for their preparation and pharmaceutical compositions |
| 11/15/1989 | EP0341910A2 Cephalosporins, process for their preparation, intermediates and pharmaceutical compositions |
| 11/15/1989 | EP0341895A1 Amino acids in the treatment of neurodegenerative disorders |
| 11/15/1989 | EP0341860A1 Benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of use |
| 11/15/1989 | EP0341837A2 Glutamic acid derivatives |
| 11/15/1989 | EP0341810A2 Use of phytic acid as an antidote for alcoholic poisoning |
| 11/15/1989 | EP0341774A1 Pharmaceutical solutions of triamterene |
| 11/15/1989 | EP0341754A2 Use of carbamate or thiocarbamate derivatives for treatment of fungal infections |
| 11/15/1989 | EP0341735A1 N-acetyl-3-fluoroneuraminic acid as antiviral drug |
| 11/15/1989 | EP0341722A2 The use of thiadiazole oxides for preparing a pharmaceutical composition for treating gastrointestinal motility disorders |
| 11/15/1989 | EP0341681A2 6-Phenoxymethyl-4-hydroxytetrahydropyran-2-ones and 6-thiophenoxymethyl-4-hydroxytetrahydropyran-2-ones, the corresponding dihydrocarboxylic-acid derivatives, salts and esters, process for preparing these compounds, their use as medicines, pharmaceutical compositions and phenols and thiophenols |
| 11/15/1989 | EP0341661A2 Peptide-drug compositions containing alpha-aminoboronic acid derivatives |
| 11/15/1989 | EP0341649A1 Antibiotic aranorosin, microbiological process for its preparation and its use as a medicament |
| 11/15/1989 | EP0341624A2 Method of effecting immunosuppression |
| 11/15/1989 | EP0341607A2 Anticoagulant peptide alcohols |
| 11/15/1989 | EP0341584A1 Soft capsular preparation of sodium picosulfate |
| 11/15/1989 | EP0341571A1 Hydrazinocarbonyloxylabdanes, a process for their preparation and their use as medicaments |
| 11/15/1989 | EP0341559A2 Synergistic mixtures and their therapeutical use |
| 11/15/1989 | EP0341558A2 Use and agent for diminishing the secondary effects of TNF |
| 11/15/1989 | EP0341557A1 3-pyrrolidinylthio-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid derivatives and their preparation |
| 11/15/1989 | EP0341551A1 Alkenoic acid derivatives |
| 11/15/1989 | EP0341527A2 Agent for increasing animal growth |
| 11/15/1989 | EP0341493A2 Optically active pyridonecarboxylic acid derivatives |
| 11/15/1989 | EP0341481A1 N-heterocyclic alcohol derivatives |
| 11/15/1989 | EP0341409A1 Platinum (II) complexes, their preparation and use as antitumour agents |
| 11/15/1989 | EP0341300A1 Stimulation of stem cell growth by the bryostatins. |
| 11/15/1989 | EP0341264A1 Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction) |
| 11/15/1989 | CN1037153A Topically applied gold organic complex |
| 11/15/1989 | CN1037151A Process for preparation of beta-lactam derivatives |
| 11/15/1989 | CN1037150A Pyranobenzoxadiazole derivatives |
| 11/15/1989 | CN1037149A 3-alkenyl-1-azabicyclo (3.2.0) hept-2-ene-2-carboxylic acid compounds |
| 11/15/1989 | CN1037148A Pyrimidine and purine 1,2-butadiene-4-ols as anti-retroviral agents |
| 11/15/1989 | CN1037145A N-substituted n-amino-pyrroles |
| 11/15/1989 | CN1037144A Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 11/15/1989 | CN1037142A 5-substituted ornithine derivatives |
| 11/14/1989 | US4880939 2,5,6,7-tetranor-18,18,19,19-tetradehydro-4,8-inter-m-phenylene PGI2 derivatives |
| 11/14/1989 | US4880930 Psychotropic acyclic amide derivatives |
| 11/14/1989 | US4880922 Bactericides |